UPSIDA & JNPA Pact to Boost Lalitpur Pharma Park as Global Exports Hub

UPSIDA & JNPA pact is set to reshape India’s pharma export landscape.

The Uttar Pradesh State Industrial Development Authority (UPSIDA) partners with Jawaharlal Nehru Port Authority (JNPA) to position the Lalitpur Pharma Park as a global export hub.

The UPSIDA & JNPA pact focuses on building a seamless logistics network that connects the upcoming park to international markets.

Under this agreement, Lalitpur Pharma Park will gain direct access to global shipping routes through JNPA, India’s largest container port.

The plan integrates rail connectivity via the Dedicated Freight Corridor and the Dadri–Khurja link, enabling faster and cost-effective transportation of pharmaceutical goods. This move is expected to reduce transit time and improve supply chain efficiency for exporters.

Also Read: Bridging Collaboration Gaps to Boost India's Pharma Discovery

The Lalitpur Pharma Park, spread across a large industrial area in Uttar Pradesh, is being developed as a major center for bulk drugs, APIs, and formulations. With improved connectivity under the UPSIDA JNPA pact, the park is likely to attract significant investment and encourage pharmaceutical companies to set up manufacturing units.

Officials believe the partnership will strengthen India’s position in global pharma trade by ensuring smoother export processes and better access to over 200 international ports. The initiative also aligns with the state’s broader goal of becoming a leading pharmaceutical manufacturing hub.

While the project offers strong growth potential, its success will depend on timely infrastructure execution and stable global trade conditions. Still, the agreement marks a strategic step toward boosting pharma exports and building a globally competitive supply chain from Uttar Pradesh.